ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• eCOA Predictions For 2022

  Dive into the prediction that the rapid adoption of eCOAs will continue to grow in 2022, as sponsors acknowledge how useful these tools have become in decentralized clinical trial (DCT) settings.

• Simplifying The Data Journey From EHR To EDC

  Explore how open API architecture represents a significant advancement in the integration of EHR and EDC systems, enhancing the potential of EHR data for clinical research.

• Measuring The True Patient Experience

  Utilizing the insights covered in this article can inform the design and implementation of cancer trials, ultimately contributing to improved patient care and treatment outcomes.

• Key Takeaways From The Recent FDA DCT Draft Guidance

  Get an overview of draft perspectives and key points to reinforce decentralized clinical trial training, oversight, and risk assessment to guarantee a study's integrity, patient safety, and success.

• Better Data, Better Decisions

  Learn how to achieve greater certainty in clinical trial financial management by leveraging adaptive, accurate, and defendable fair market value.

• What Are Decentralized Clinical Trials (DCTs)?

  Discover how DCTs leverage “virtual” tools, such as telemedicine, sensory-based technologies, wearable medical devices, and direct delivery of study drugs and materials to patients’ homes.

• Clinical Data Needs Smart Automation Now for a Better AI Future

  AI holds the potential to enhance clinical trial efficiency, but it relies on a foundation of clean data and intelligent automation to be effective.

• Simplifying The Regulatory Submission Process With A Modern CTMS

  Working in collaboration with industry representatives, explore the value that pulling the regulatory submission process into a modern Clinical Trial Management System (CTMS) could have.

• Accelerated Approval As The New "Norm" In Gene Therapy For Rare Diseases

  Gene therapy has revolutionized treatment prospects for rare genetic disorders by enabling corrective or replacement strategies at the molecular level.

• To Counter Bias, Counterbalance

  It’s easy to overlook the effects a survey’s format can have on responses, but those effects are potent sources of bias. Modern EDC allows you to systematically vary both question and response option order. This practice, called counterbalancing, guards against unwanted order effects.